Scientists map how childhood liver tumors transform into cancer
Researchers have identified the exact genetic steps that turn a benign childhood liver tumor into a deadly cancer, opening doors to early detection and prevention strategies. The discovery reveals two specific mutations must occur together—a finding that could reshape how doctors monitor and treat rare pediatric cancers.
Originaltitel: Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.
Japansk forskargrupp har kartlagt den genetiska vägen från benign mesenchymal hamartom i levern (MHL) till malignt undifferentierat embryonalt sarkom (UESL) hos barn. Multi-omics-analysen av 18 UESL- och sex MHL-fall identifierade strukturella varianter i C19MC-klustret — överrepresenterat i alla tumörer — samt TP53-mutationer enbart i UESL. Funktionsstudier visade att C19MC-överexpression tillsammans med TP53-förlust driver maligniteten; ingen faktor räcker ensamt. Spatial transcriptomik på ett blandat MHL-UESL-väv avslöjade klonal evolution. Fynden definierar en tvåstegs-transformation och pekar på två kooperativa genetiska drivare. För patologer och barnonkologer ökar kunskapen om malignitetsrisken vid MHL och möjliggör potentiell genbaserad riskstratifiering. Fynden kan också underbygga utvecklingen av målriktade terapier mot C19MC eller TP53-vägen i dessa sällsynta tumörer.
Undifferentiated embryonal sarcoma of the liver (UESL) and mesenchymal hamartoma of the liver (MHL) are rare pediatric liver tumors with poorly understood oncogenic mechanisms. Although UESL occasionally arises from MHL, the relationship between these entities remains elusive. Here, we conducted comprehensive multi-omics profiling of 18 UESL and six MHL cases, and identified structural variants (SVs) involving the C19MC miRNA cluster in all tumors, resulting in robust overexpression of C19MC miRNAs. While mutations in TP53 were detected in all UESL samples, they were absent from MHL. Functional studies demonstrated that overexpression of C19MC miRNAs alone was insufficient for transformation, but acted synergistically with TP53 loss to drive oncogenicity. Spatial transcriptomics performed on a tumor sample containing a composite MHL-UESL lesion revealed pseudo-temporal gene expression trajectories and clonal diversification. Collectively, these findings delineate a stepwise malignant transformation from MHL to UESL, and reveal the underlying cooperative genetic events.